[1] 陈万青,郑荣寿,张思维,等.2012年中国恶性肿瘤发病和死亡分析[J].中国肿瘤,2016,25(1):1-8.
[2] 季加孚.从中国胃肠肿瘤外科联盟相关数据分析我国早期胃癌诊治现状和发展趋势[J].中国实用外科杂志,2019,39(5):419-423.
[3] Ahn H S, Lee H J, Yoo M W, et al. Changes in clinicopathological features and survival after gastrectomy for gastric cancer over a 20-year period [J].Br J Surg, 2011, 98(2): 255-260.
[4] Ferlay J,Colombet M,Soerjomataram I,et al.Estimating the global cancer incidence and mortality in 2018:GLOBOCAN sources and methods[J].Int J Cancer, 2019, 144(8): 1941-1953.
[5] 杨 昆. 日本《胃癌治疗指南》临床问题解读[J].5 版.中国实用外科杂志,2019,39(1): 54-55.
[6] 苗儒林,李子禹,武爱文.中国胃肠肿瘤外科联盟数据报告(2014-2016)[J].中国实用外科杂志,2018,38(1):90-93.
[7] Kim W, Kim H H, Han S U, et al. Korean Laparo-endoscopic Gastrointestinal Surgery Study(KLASS)Group. Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for Stage I gastric cancer:Short-term outcomes from a multicenter randomized controlled trial(KLASS-01)[J].Ann Surg,2016,263(1):28-35.
[8] Hu Y, Huang C, Sun Y, et al. Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer:a randomized controlled trial[J].J Clin Oncol,2016,34(12):1350-1357.
[9] Watnabe M, Miyata H, Gotoh M, et al. Total gastrectomy risk moldel: data from 20,011 Japanese patients in a nationwide internet-based database[J]. Ann Surg, 2014,260(6):1034-1039.
[10] Yang J, Zhang X H, Huang Y H, et al. Diagnosis and treatment of abdominal arterial bleeding after radical gastrectomy: a retrospective analysis of 1875 consecutive resections for gastric cancer[J].J Gastrointest Surg, 2016, 20(3): 510-520.
[11] 束宽山, 孙学工, 苏昭然, 等.胃癌根治术联合D2淋巴结清扫术后吻合口漏的危险因素分析[J].中华临床医师杂志 (电子版) , 2012, 6 (18) : 164-165.
[12] Tsou C C, Lo S S, Fang W L, et al. Risk factors and management of anastomotic leakage after radical gastrectomy for gastric cancer[J]. Hepatogastroenterology, 2011, 58(105): 218-223.
[13] Shu X, Ji J, Li X. Cancer risk among patients hospitalized for Type1 diabetes mellitus:apopulation- based cohort study in Sweden [J]. Diabet Med, 2010, 27(7):791-797.
[14] Brem H, Tomic- Canic M. Cellular and molecular basis of wound healing in diabetes [J]. J Clin Invest, 2007, 117(5): 1219-1222.
[15] Suding P, Jensen E, Abramson M A, et al. Definitive risk factors for anastmotic leaks in elective open colonrectal resection [J]. Arch Surg, 2008, 143(9): 907-912.
[16] Onodera H, Ikeuchi D, Nagayama S, et al. Weakness of anastomotic site in diabetic rats is caused by cha Nges in the integrity of newly formed collagen [J]. Dig Surg, 2004, 21(2):146-151.
[17] 田红刚 .影响食管癌根治性切除术后吻合口瘘发生的危险因素Logistic回归分析[J].临床医学研究与实践,2019,4(20):87-89.
[18] Fujitani K, Ajani J A, Crane C H, et al. Impact of induction che motherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocar cinoma of the stomach or gastroesophageal junction[J]. Ann Surg Oncol, 2007, 14(7): 2010-2017.
[19] Sun C, Zhou L Q, Shao X Z, et al. The influence of hypoalbuminemia on postoperative complications of esophageal cancer[J]. Hebei Med, 2015, 21(4): 570-573.
[20] Kodera Y, Sasako M, Yamamoto S, et al. Identification of risk factors for the development of complications following extended and super-extended lymphadenectomies for gastric cancer[J].Br J Surg,2005,92: 1103-1109.
[21] Lo C H, Chen J H, Wu C W, et al. Risk factors and management of intra-abdominal infection after extended radical gastrectomy[J].Am J Surg, 2008, 196:741-745.
[22] Yasuda K, Shiraishi N, Adachi Y, et al. Risk factors for complications following resection of large gastric cancer[J].Br J Surg,2001,88(6): 873-877.
[23] Nagasako Y, Satoh S, Isogaki J, et al. Impact of anastomotic complications on outcome after laparoscopic gastrectomy for early gastric cancer[J]. Br J Surg, 2012, 99(6): 849-854.
[24] 李一博,董剑宏.经腹 Siewert Ⅱ、Ⅲ型食管胃结合部腺癌根治术后吻漏的研究现状 [J].中华临床医师杂志(电子版),2015,9(9):1715-1718.
[25] Deguchi Y, Fukagawa T, Morita S, et al.Identification of risk factors for esophagojejunal anastomotic leakage after gastric surgery[J].World J Surg, 2012, 36:1617-1622.
[26] Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3)[J]. Gastric Cancer, 2011, 14(2): 113-123.
[27] 中国医师协会内镜医师分会腹腔镜外科专业委员会. 中国腹腔镜胃癌根治手术质量控制专家共识(2017版)[J]. 中华消化外科杂志, 2017,16(6): 539-547.
[28] Oshi M, Kunisaki C, Miyamoto H, et al. Risk factors for anastomotic leakage of esophagojejunostomy after laparoscopy- assisted total gastrectomy for gastric cancer[J]. Dig Surg, 2017, 35(1):28-34.
[29] Usui S, Tashiro M, Haruki S, et al. Spleen preservation versus splenectomy in laparoscopic total gastrectomy with D 2 lymphadenectomy for gastric cancer: a comparison of short-term outcomes[J]. Asian J Endosc Surg, 2016, 9(1):5-13.
[30] 陈起跃,吕陈彬,郑朝辉,等.腹腔镜辅助根治性全胃切除术治疗 Siewert Ⅱ、Ⅲ型胃食管结合部腺癌疗效分析[J].中国实用外科杂志,2016,36( 9) : 995-1000.
[31] 黄昌明,郑朝辉,陆 俊.完全腹腔镜胃癌手术消化道重建专家共识及手术操作指南( 2018 版) [J].中国实用外科杂志, 2018,38(8):833-839.
[32] 赵紫罡,王 卫,杨 瑞,等.多学科合作模式下快速康复外科在胃肠道肿瘤围手术期中的应用[J].中国肿瘤,2012,8: 624-626.
[33] 许彬东,黄国忠,陈 豪,等. 术前肠内营养对食管癌围手术期营养状态、免疫功能与应激反应的影响[J]. 肠外与肠内营养, 2018, 25(4): 204-208.
[34] Weimann A, Braga M, Carli F, et al. ESPEN guideline: clinical nutrition in surgery [J]. Clin Nutr, 2017, 36(3):623-650.
[35] Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients [J], Clin Nutr, 2017,36(1):11-48.
[36] 李增宁,陈 伟,齐玉梅,等. 肿瘤患者特殊医学用途配方食品应用专家共识[J]. 肿瘤代谢与营养电子杂志, 2016, 3(2): 95-99.
[37] 李志民.胃癌根治术后早期肠内营养支持的效果观察[J].河南外科学杂志,2015,20(6):34-36.
[38] 袁琮玮,李俊生,嵇振岭,等.全肠外营养及早期肠营养在胃癌全胃切除术后患者中的对比研究[J].中国普外基础与临床杂志,2010,17(4):357.
[39] Mazaki T, Ebisawa K. Enteral versus parenteral nutrition after gastrointestinal surgery: a systematic review and meta-analysis of randomized controlled trials in the English literature[J].J Gastrointest Surg,2008,12(4):739-755.
[40] Portanova M. Successful enteral nutrition in the treatment of esophagojejunal fistula after total gastrectomy in gastric cancer patients[J]. World J Surg Oncol, 2010, 8:71.
[41] Cheng Ying, Zhang Junfeng, Zhang Liwei, et al.Enteral immunonutrition versus enteral nutrition for gastric cancer patients undergoing a total gastrectomy: a systematic review and meta-analysis [J].BMC Gastroenterology,2018,18:11.
[42] 王新颖. 2016 年成人危重症病人营养支持治疗实施与评价指南解读[J]. 肠外与肠内营养, 2016, 23(5): 263-269.
[43] Arends J, Bachmann P, Baracos V, et al. Espen guidelines on nutrition in cancer patients[J].Clin Nutr,2017,36(1):11-48.
[44] August D A, Huhmann M B. Directors ASFPAEN Clinical Guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation [J]. JPEN J Parenter Enteral Nutr, 2009, 33(5):472-500.